Chief Officers:
President: Xiaodan Mei, Ph.D. , President of Biteomics,Inc.
Vice President: Yanshen Xie, Ph.D. Principal Scientist at Human Genome Science.
Genral Secretory: Xiaodi Guo, Ph.D., Shire Lab, Inc.Shuoyu Zhang, Ph.D. (Kobin)
Treasure: Kaibin Wu (Metlife)

Executive Board Directors:
Xiaodan Mei, Ph.D. (President of Biteomics, Inc.),Yanshen Xie, Ph.D., Jihong Wang, Ph.D.; Zhinan Xia, Ph.D. (Staff Scientist, Harvard); Peng Jiao, Ph.D.(MIT); Anna Zhou, Ph.D.; Ming Yang, Ph.D.(Cubist); Patrick Wang, Ph.D. (Northeastern University);Kevin Xie, Ph.D.(Vertex Pharmaceuticals); Taco Chen, Ph.D. (Xtrum, Inc.); John (Xuanqi) Zhang, MD (Harvard Medical School,Physician); Sylvia Shuoyu Zhang, MBA (Kopin); Qinsheng Gao, MD, Ph.D., Jim Hung, Ph.D. (CEO, President, New Dimension Research); (Biology and Database, Harvard University); Dale Hu,Ph.D. (Software Engineer, Realtime); Henry Ma, Ph.D. (JohnHancock, Financing Officer); Suo Zhuang, Ph.D. (Economic Specialist); Ying Hou (Associate Scientist, Neogeneisis); Kaibin Wu(Insurance Specialist, Metlife); Ying Jing (BU Ph.D.) Ding Wu (Wellesley College Student); Adam Chang, Ph.D. (Research Fellow, Millennium); Yanyan Xin,Ph.D. (Senior Scientist, Neogeneisis); Carlos Fareman, Ph.D. (Althexis); Qinping Wang, Ph.D. (Assistant Professor,Tufts); Yansheng Xie, Ph.D. (Scientist, Human Life Science, New Jersey); Lixin Zhang, Ph.D. (Cetek); Liya Rong, AD (Harvard Law School) ;Wangni Tian Ph.D. (President of Althex); Lexin Liu, Ph.D. (Harvard Univ); Lin Sun, Ph.D (Phyllos); Dr. Patric Z. Li (Internet & Networking), Dr. Da Feng Wen (Power Electronics, Philips Lab), Dr. Hairo Ma (Wireless, Motorola, Inc.), Dr. Jingqian Liu (Turlid Pharmaceuticals), Dr. Xiaodi Guo (Formulation Expert, Shire Lab, Marryland), Dr. Liangli Yu (Assistant Proffesor, Colorado State University), Mr. Richard Chiang (Kopin), Dr. Junming Gao (Cisco)

Honorary Members and Scientific Advisory Board: Dr.Roif M Zinkernagl(1996 Nobel Prize Laureate), Khavinson, Ph.D.(Member of the Russian Academy of Natural Sciences), Hunter, Ph.D. (Member of Royal Society of New Zealand), Zuze Wu, Ph.D.(The Member of Chinese Academy of Sciences), Dr.Kenneth Fong(Kenson Venture), Dr. Richard J. Roberts(New England Biolab), Dr. John Collier, (Harvared), Dr. Arny Demain(MIT), Dr. Jaw-Kai Wong(Hawaii U.), Dr. Ferid Murad(Texas U. Hhuston), Dr. James Waters (Waters), Dr. Ted Cruisberg(WPI), Dr. Alexandra Flemming(Boston Scienfic, Inc), Dr. Eugen Koveski(Millennium), Dr.Xiaodong Wang(Professor of Biochemistry), Dr. Hans Fliri(Cetek), Dr. Prof. Jianzhu Chen, Ph.D. (MIT.); Dr.Haian Fu (Emory); Dr.Jim Xiao (BU); Prof. Patrick Wang, Ph.D. (Northeastern University); Jim Hung, Ph.D. (CEO of Newdimension Research, Assistant Professor, Tufts University); Yibin Xiang, Ph.D. Director of Chemistry, GTC， Prof. Tian Xu (Yale), Prof. Xingwang Deng (Yale), Prof. Xingli Lin (OMRF), Prof. Jun Liu (MIT/John Hopkins), Prof. Wenyuan Shi (UCALA), (Dr. Xinyuan Liu, CAS, Shanghai), Dr. Henry Yang (Huada Genomic Center).

Coordinators:
Alfred Shang (Economics Department of Harvard University. ); Dr. Paul Armstrong-Taylor (Harvard University), Xinchu Gu (Director at Shanghai New Drug Evaluation Center)., Ellen Zhang (ShanghaiMedical Devices), Gang Xu (Lucent) ; Jieming Hu (England), Dr. Henry Hu (Ireland); Dr.Xishu Cui(Japan Zhenxin), Dr.Wu Cui (Ruassia); Dr. Qi Wang (Landon, Britain), Dr.Jack Lai (Taiwan); Dr. Qiguang Zhao (Belgium),Dr.Xueliang Liu (UT, Germany); Ms. Yan Song (France).